This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ERx (Electronic Prescribing/e-Prescribing) Market By Hardware, Software, Services, End-users (Medical Group Practice & Hospitals), Products (Integrated & Standalone Systems) & Deployment (Licensed, Web-hosted & Cloud) - Global Forecasts To 2017









NEW YORK, Jan. 17, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

eRx (Electronic Prescribing/e-Prescribing) Market By Hardware, Software, Services, End-users (Medical Group Practice & Hospitals), Products (Integrated & Standalone Systems) & Deployment (Licensed, Web-hosted & Cloud) – Global Forecasts to 2017

http://www.reportlinker.com/p01083652/eRx-Electronic-Prescribing/e-Prescribing-Market-By-Hardware-Software-Services-End-users-Medical-Group-Practice--Hospitals-Products-Integrated--Standalone-Systems--Deployment-Licensed-Web-hosted--Cloud-–-Global-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

 

Electronic prescribing can be considered as one important aspect of a larger technological transformation in the healthcare industry. Electronic prescribing is rapidly becoming a standard of practice in the developed countries of the world and a significant rise is seen in the adoption rate among hospitals and office-based prescribers. eRx empowers more informed decision making by making patient formulary, eligibility and medication history information available at the point that prescribing decisions are made. This report analyzes the global market for e-Prescribing systems by product (stand-alone and integrated), deployment modes, usage modes, components, end-users, and geography.

 

The healthcare industry is witnessing an increased adoption of eRx systems due to the pressing need to curtail healthcare costs, while maintaining the quality of care provided to patients and reduce medication errors and adverse drug events (ADEs). This is expected to drive the market at a CAGR of 26% from 2012 to 2017. The global e-prescription market was pegged at $170 million in 2011 and North America is expected to be the leading region to drive the growth of the market due to increased adoption of eRx systems in this region, particularly in the U.S.

 

High cost of the e-Prescribing systems and resistance to adoption of technology, by the physician fraternity, restrain the growth of this market. The market is also witnessing a growing demand for integrated e-prescription systems, facilitating the healthcare community to shift towards the implementation of a complete electronic health record system.

1 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs